An anti-tumor protein PFAP specifically interacts with cholesterol-enriched membrane domains of A549 cells and induces paraptosis and endoplasmic reticulum stress

Int J Biol Macromol. 2024 Apr;264(Pt 2):130690. doi: 10.1016/j.ijbiomac.2024.130690. Epub 2024 Mar 6.

Abstract

Nowadays, non-small cell lung cancer (NSCLC) is still one of the most life-threatening diseases in the world. In previous studies, a fungal protein PFAP with anti-NSCLC properties was isolated and identified from Pleurotus ferulae lanzi. In this study, the amino acid sequence of PFAP was analyzed and found to be highly homologous to the aegerolysin family. PFAP, like other members of the aegerolysin family, specifically recognizes lipid raft domains rich in cholesterol and sphingomyelin, which is probably its specific anti-tumor mechanism. Previous studies have shown that PFAP can induce AMPK-mediated autophagy and G1-phase cell cycle arrest in A549 lung cancer cells. This study further revealed that PFAP can also induce paraptosis and endoplasmic reticulum stress (ERS) in A549 cells in vitro by targeting AMPK. PFAP induces multi-pathway death of A549 cells, and thus demonstrates its potential value for developing new drugs for NSCLC.

Keywords: Endoplasmic reticulum stress (ERS); Lipid raft domains; PFAP; Paraptosis.

MeSH terms

  • A549 Cells
  • AMP-Activated Protein Kinases
  • Apoptosis
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Cell Line, Tumor
  • Endoplasmic Reticulum Stress
  • Humans
  • Lung Neoplasms* / pathology
  • Paraptosis

Substances

  • AMP-Activated Protein Kinases